SEC Form 4 insider trading filings tracked in real time from EDGAR

Cummings Keith Lamont — Chief Financial Officer

Insider trading activity for Cummings Keith Lamont sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: PLIANT THERAPEUTICS, INC.
  • Total insider trades: 14
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Apr 17, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 113,300 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 113,300 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 110,500 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 110,500 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 76,200 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 76,200 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 124,000 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 124,000 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 74,250 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 74,250 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 18,198 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 18,198 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. BUY 76,047 N/A
Apr 17, 2026 Cummings Keith Lamont PLRX PLIANT THERAPEUTICS, INC. SELL 76,047 N/A

← All executives · Full trades feed